Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?
European Heart Journal
19 May 2017
Organised by: 

Contributors

Karin H. Humphries
Author

G.B. John Mancini
Author
You may be interested in
Webinar
10 January 2023

Congress Presentation
Congress Presentation
1 September 2025



